leukemia
Leukemia was first identified by German pathologist Rudolf Virchow in 1847. The cause of leukemia is the abnormal functioning of the hematopoietic tissue in the bone marrow due to mutations in the DNA in the cells. Stem cells in the bone marrow can produce thousands of red and white blood cells every day. Leukemia patients overproduce immature white blood cells, which interferes with other work of the bone marrow, which reduces the bone marrow's ability to produce other blood cells. Leukemia can spread to the lymph nodes, spleen, liver, central nervous system and other organs.
-
Site of disease:
Blood vessels -
Infectious :
Not contagious -
Frequent population:
Children and Youth -
Related symptoms:
Tarry stools Enlarged liver and spleen Bleeding gums Bone tenderness Secondary infection -
Concurrent disease:
Related Drugs
Cyclophosphamide
Indication: Cyclophosphamide is one of the most widely used anticancer drugs. It has significant effects in treating malignant lymphoma, multiple myeloma, breast cancer, small cell lung cancer, ovarian cancer, neuroblastoma, retinoblastoma, Ewing's tumor, soft tissue sarcoma, acute leukemia and chronic lymphocytic leukemia. Currently, cyclophosphamide is often used in clinical treatment in combination with other anticancer drugs. This drug is also used as an immunosuppressant to treat non-tumor diseases.
Cyclophosphamide
Indication: Cyclophosphamide is one of the most widely used anticancer drugs. It has significant effects in treating malignant lymphoma, multiple myeloma, breast cancer, small cell lung cancer, ovarian cancer, neuroblastoma, retinoblastoma, Ewing's tumor, soft tissue sarcoma, acute leukemia and chronic lymphocytic leukemia. Currently, cyclophosphamide is often used in clinical treatment in combination with other anticancer drugs. This drug is also used as an immunosuppressant to treat non-tumor diseases.
Manufacturer:
Shanxi Zhendong Taisheng Pharmaceutical Co., Ltd.
Cyclophosphamide
Indication: Cyclophosphamide is one of the most widely used anticancer drugs. It has significant effects in treating malignant lymphoma, multiple myeloma, breast cancer, small cell lung cancer, ovarian cancer, neuroblastoma, retinoblastoma, Ewing's tumor, soft tissue sarcoma, acute leukemia and chronic lymphocytic leukemia. Currently, cyclophosphamide is often used in clinical treatment in combination with other anticancer drugs. This drug is also used as an immunosuppressant to treat non-tumor diseases.
Manufacturer:
Shanxi PUDE Pharmaceutical Co., Ltd.
Cyclophosphamide
Indication: Cyclophosphamide is one of the most widely used anticancer drugs. It has significant effects in treating malignant lymphoma, multiple myeloma, breast cancer, small cell lung cancer, ovarian cancer, neuroblastoma, retinoblastoma, Ewing's tumor, soft tissue sarcoma, acute leukemia and chronic lymphocytic leukemia. Currently, cyclophosphamide is often used in clinical treatment in combination with other anticancer drugs. This drug is also used as an immunosuppressant to treat non-tumor diseases.
Manufacturer:
Zhejiang Hisun Pharmaceutical Co., Ltd.
Methotrexate tablets
Indication: 1. All types of acute leukemia, especially acute lymphocytic leukemia, malignant lymphoma, non-Hodgkin's lymphoma, mycosis fungoides, and multiple myelopathy; 2. Head and neck cancer, lung cancer, various soft tissue sarcomas, and psoriasis; 3. Breast cancer, ovarian cancer, cervical cancer, malignant hydatidiform mole, choriocarcinoma, and testicular cancer.
Manufacturer:
Hunan Zhengqing Pharmaceutical Co., Ltd.
Recombinant human interferon α2b injection
Indication: 1. Used to treat certain viral diseases, such as acute and chronic viral hepatitis, herpes zoster, and genital warts. 2. Used to treat certain tumors, such as hairy cell leukemia, chronic myeloid leukemia, multiple myeloma, non-Hodgkin's lymphoma, malignant melanoma, renal cell carcinoma, laryngeal papilloma, Kaposi's sarcoma, ovarian cancer, basal cell carcinoma, bladder cancer, etc.
Manufacturer:
Anhui Anke Biotechnology (Group) Co., Ltd.
Ifosfamide
Indication: 1. This product has a wide anti-tumor spectrum and is mainly suitable for soft tissue tumors, testicular tumors, malignant lymphomas, lung cancer, breast cancer, ovarian cancer, cervical cancer and childhood tumors; 2. Used for anti-tumor: leukemia, spermatogonial testicular cancer, lung cancer, non-Hodgkin's lymphoma, cervical cancer, ovarian cancer and recurrent and refractory solid tumors.
Ifosfamide
Indication: 1. This product has a wide anti-tumor spectrum and is mainly suitable for soft tissue tumors, testicular tumors, malignant lymphomas, lung cancer, breast cancer, ovarian cancer, cervical cancer and childhood tumors; 2. Used for anti-tumor: leukemia, spermatogonial testicular cancer, lung cancer, non-Hodgkin's lymphoma, cervical cancer, ovarian cancer and recurrent and refractory solid tumors.
Manufacturer:
Shandong Ruiying Pioneer Pharmaceutical Co., Ltd.
Ifosfamide
Indication: 1. This product has a wide anti-tumor spectrum and is mainly suitable for soft tissue tumors, testicular tumors, malignant lymphomas, lung cancer, breast cancer, ovarian cancer, cervical cancer and childhood tumors; 2. Used for anti-tumor: leukemia, spermatogonial testicular cancer, lung cancer, non-Hodgkin's lymphoma, cervical cancer, ovarian cancer and recurrent and refractory solid tumors.
Manufacturer:
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Ifosfamide
Indication: 1. This product has a wide anti-tumor spectrum and is mainly suitable for soft tissue tumors, testicular tumors, malignant lymphomas, lung cancer, breast cancer, ovarian cancer, cervical cancer and childhood tumors; 2. Used for anti-tumor: leukemia, spermatogonial testicular cancer, lung cancer, non-Hodgkin's lymphoma, cervical cancer, ovarian cancer and recurrent and refractory solid tumors.
Related Ingredients